Norah A Albekairi1, Sanaalarab Al-Enazy1, Shariq Ali1, Erik Rytting1,2. 1. Department of Pharmacology & Toxicology, University of Texas Medical Branch, Galveston, TX 77555, USA. 2. Department of Obstetrics & Gynecology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Abstract
BACKGROUND: Fetal arrhythmias can lead to fetal congestive heart failure and hydrops fetalis. Digoxin (the first-line treatment) has low transplacental permeability and high risk of maternal side effects. Biodegradable digoxin-loaded PEGylated poly(lactic-co-glycolic acid) nanoparticles may increase digoxin transport across BeWo b30 cell monolayers (an in vitro model of trophoblast in human placenta) by reducing the drug's interaction with P-gp. Results/methodology: The nanoparticles showed high encapsulation efficiency and sustained release over 48 h. Transport studies revealed significantly increased permeability across BeWo cell layers of digoxin-loaded nanoparticles when compared with free digoxin. P-gp inhibition also increased the permeability of digoxin, but not digoxin-loaded nanoparticles. CONCLUSION: This represents a novel treatment strategy for fetal cardiovascular disease which may improve maternal and fetal outcomes.
BACKGROUND: Fetal arrhythmias can lead to fetal congestive heart failure and hydrops fetalis. Digoxin (the first-line treatment) has low transplacental permeability and high risk of maternal side effects. Biodegradable digoxin-loaded PEGylated poly(lactic-co-glycolic acid) nanoparticles may increase digoxin transport across BeWo b30 cell monolayers (an in vitro model of trophoblast in human placenta) by reducing the drug's interaction with P-gp. Results/methodology: The nanoparticles showed high encapsulation efficiency and sustained release over 48 h. Transport studies revealed significantly increased permeability across BeWo cell layers of digoxin-loaded nanoparticles when compared with free digoxin. P-gp inhibition also increased the permeability of digoxin, but not digoxin-loaded nanoparticles. CONCLUSION: This represents a novel treatment strategy for fetal cardiovascular disease which may improve maternal and fetal outcomes.
Authors: Sarah J Hemauer; Svetlana L Patrikeeva; Tatiana N Nanovskaya; Gary D V Hankins; Mahmoud S Ahmed Journal: Biochem Pharmacol Date: 2009-07-08 Impact factor: 5.858
Authors: Peter Wick; Antoine Malek; Pius Manser; Danielle Meili; Xenia Maeder-Althaus; Liliane Diener; Pierre-Andre Diener; Andreas Zisch; Harald F Krug; Ursula von Mandach Journal: Environ Health Perspect Date: 2009-11-12 Impact factor: 9.031
Authors: John T Szilagyi; Ludwik Gorczyca; Anita Brinker; Brian Buckley; Jeffrey D Laskin; Lauren M Aleksunes Journal: Toxicol Sci Date: 2019-04-01 Impact factor: 4.849
Authors: Mansi Shah; Luke Bourner; Shariq Ali; Sanaalarab Al-Enazy; Menatallah M Youssef; Morgan Fisler; Erik Rytting Journal: Separations Date: 2018-01-24